EYES - Second Sight Medical Products, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.7650
-0.0150 (-0.84%)
As of 11:15AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.7800
Open1.7800
Bid1.7600 x 1400
Ask1.7700 x 1000
Day's Range1.7600 - 1.7900
52 Week Range1.0500 - 2.5800
Volume18,390
Avg. Volume226,631
Market Cap118.386M
Beta1.42
PE Ratio (TTM)N/A
EPS (TTM)-0.5370
Earnings DateJul 30, 2018 - Aug 3, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
Trade prices are not sourced from all markets
  • Business Wire3 days ago

    Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development

    Second Sight Medical Products, Inc. (EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, today announced that the Company has received a $1.6 million grant (with the intent to fund $6.3 million over five years subject to annual review and approval) from the National Institutes of Health (NIH) to fund the “Early Feasibility Clinical Trial of a Visual Cortical Prosthesis” that commenced in January 2018.

  • Business Wire17 days ago

    Second Sight Appoints Pat Ryan Chief Operating Officer

    Second Sight Medical Products, Inc. (EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, announced today that Pat Ryan has been appointed Chief Operating Officer, effective immediately. In this newly created role, Mr. Ryan will assume responsibility for Research & Development, Manufacturing, Planning & Materials, Quality Assurance, and Information Technology. “Pat brings a wealth of knowledge from both large and small medical device firms, and we are delighted to welcome him to the Second Sight team.

  • GlobeNewswire25 days ago

    Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, Aug. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of C&J ...

  • Business Wirelast month

    Second Sight to Present at Investor Conferences in September

    The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.secondsight.com, under the Investor Relations section. Second Sight Medical Products, Inc. develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals.

  • Second Sight Medical Products (EYES): Moving Average Crossover Alert
    Zackslast month

    Second Sight Medical Products (EYES): Moving Average Crossover Alert

    Second Sight Medical Products, Inc. (EYES) could be a stock to avoid from a technical perspective

  • Business Wirelast month

    Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

    Second Sight Medical Products, Inc. (EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that it has entered into a stock purchase agreement effective August 14, 2018 with entities beneficially owned by Gregg Williams, Chairman of the Board of Directors, for the purchase of 3,225,807 shares of common stock priced at $1.55 per share, the last reported sale price of the common stock on the effective date. This placement of common stock is anticipated to yield gross proceeds of approximately $5,000,000 to the Company. No warrants or discounts were provided and no placement agent or investment banking fees were incurred in connection with this transaction.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of EYES earnings conference call or presentation 7-Aug-18 8:30pm GMT

    Q2 2018 Second Sight Medical Products Inc Earnings Call

  • Associated Presslast month

    Second Sight Medical Products: 2Q Earnings Snapshot

    The Sylmar, California-based company said it had a loss of 12 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 11 cents per share. The maker of camera-based retinal ...

  • Business Wirelast month

    Second Sight Reports Second Quarter 2018 Financial Results

    -- Achieves program milestones as Orion clinical and R&D activities advance --

  • ACCESSWIRElast month

    Second Sight Medical Products, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Second Sight Medical Products, Inc. (NASDAQ: EYES ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 ...

  • Business Wire2 months ago

    Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call

    Second Sight Medical Products, Inc. (EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 second quarter financial results on Tuesday, August 7, 2018, after the close of the U.S. financial markets. Second Sight’s U.S. headquarters are in Los Angeles, California, and European headquarters are in Lausanne, Switzerland.

  • Second Sight Medical Products Inc’s (NASDAQ:EYES) Shift From Loss To Profit
    Simply Wall St.3 months ago

    Second Sight Medical Products Inc’s (NASDAQ:EYES) Shift From Loss To Profit

    Second Sight Medical Products Inc’s (NASDAQ:EYES): Second Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets prosthetic devices to restore functional vision of blind individuals in theRead More...

  • ACCESSWIRE4 months ago

    Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks

    Stock Research Monitor: EYES, SENS, and VAR LONDON, UK / ACCESSWIRE / May 23, 2018 / If you want a free Stock Review on PBH sign up now at www.wallstequities.com/registration . Ahead of today's trading ...

  • Business Wire4 months ago

    Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference

    Second Sight's mission is to develop, manufacture and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and now manufactures and markets, the Argus® II Retinal Prosthesis System.

  • Associated Press4 months ago

    Second Sight Medical Products: 1Q Earnings Snapshot

    The Sylmar, California-based company said it had a loss of 17 cents per share. Losses, adjusted for one-time gains and costs, were 14 cents per share. The maker of camera-based retinal implants posted ...

  • Business Wire4 months ago

    Second Sight Reports First Quarter 2018 Financial Results

    Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three months ended March 31, 2018.

  • Business Wire5 months ago

    Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

    Second Sight Medical Products, Inc. (EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that it has entered into a stock purchase agreement on May 3, 2018 with entities beneficially owned by Gregg Williams for the purchase of 6,756,757 shares of common stock priced at $1.48 per share, the last reported sale price of the common stock on that date. Gregg Williams is Chairman of the Board of Directors of Second Sight. This placement of common stock is anticipated to yield gross proceeds of approximately $10 million to the Company and was completed without providing warrants or discounts and without incurring any placement agent or investment banking fees in connection with this transaction.

  • Business Wire5 months ago

    Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call

    Second Sight Medical Products, Inc. (EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its 2018 first quarter financial results on Thursday, May 10, 2018, after the close of the U.S. financial markets. Second Sight’s U.S. Headquarters are in Los Angeles, California, and European Headquarters are in Lausanne, Switzerland.

  • Business Wire5 months ago

    Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company

    Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that Dr.

  • Business Wire6 months ago

    Second Sight Appoints John T. Blake Chief Financial Officer

    Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that John T.

  • Business Wire6 months ago

    Second Sight Appoints Gregg Williams as Chairman of the Board of Directors

    Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that the Board of Directors has appointed Mr.

  • Business Wire6 months ago

    Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium

    Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that Will McGuire, President and Chief Executive Officer, will present at the B.